Science Explorer Back to mapMap
Discussion
Company · Tokyo · Japan

Daiichi-Sankyo (Japan)

In research, Daiichi-Sankyo (Japan) stands highest in Health Sciences (#1,954 of 9,902 worldwide), Medicine (#1,869 of 8,541 worldwide) and Life Sciences (#2,951 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Oncology and Cardiology and Cardiovascular Medicine (Oncology is 11.8× its share of world research).

daiichisankyo.comROR OpenAlex
World rank, 2022-now
#6,522
of 22,385 · #4,741 all time
Rank in Japan
#144
of 924
Research works
5k
◆ 1% vs 2018-21
Citations
105k
21.1 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
vs its own fields
0.99×
1.00× is exactly expected
Open access
38%
world 40%
International
36%
world 18%
Daiichi-Sankyo (Japan)

What is Daiichi-Sankyo (Japan) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #1,954 of 9,902 13.9%280 #1794
MedicineField #1,869 of 8,541 14.2%269 #1729
Life SciencesDomain #2,951 of 6,403 8.8%127 #2792
Biochemistry, Genetics and Molecular BiologyField #1,464 of 2,964 9.8%86 #2249
OncologySubfield #442 of 755 19.9%63 #658

Each strip is that field's whole ranked pool, with the notch where Daiichi-Sankyo (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#1,794 #1,954
  2. Medicine#1,729 #1,869
  3. Life Sciences#2,792 #2,951
  4. Biochemistry, Genetics and Molecular Biology#2,249 #1,464
  5. Oncology#658 #442
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Daiichi-Sankyo (Japan) work in?

In 2022-now, 56% of research at Daiichi-Sankyo (Japan) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (17%), Economics, Econometrics and Finance (4%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 324 fractional works · 56.4% of its workMedicine: 310 fractional works · 54.1% of its workOncology: 76 fractional works · 13.3% of its workPulmonary and Respiratory Medicine: 45 fractional works · 7.9% of its workCardiology and Cardiovascular Medicine: 34 fractional works · 5.9% of its workRadiology, Nuclear Medicine and Imaging: 20 fractional works · 3.4% of its workSurgery: 18 fractional works · 3.2% of its workHematology: 17 fractional works · 2.9% of its workEndocrinology, Diabetes and Metabolism: 10 fractional works · 1.8% of its workEpidemiology: 9 fractional works · 1.6% of its workPublic Health, Environmental and Occupational Health: 8 fractional works · 1.3% of its workRheumatology: 7 fractional works · 1.3% of its workGenetics: 7 fractional works · 1.3% of its workPhysiology: 7 fractional works · 1.2% of its workPathology and Forensic Medicine: 6 fractional works · 1.0% of its workNeurology: 6 fractional works · 1.0% of its workInternal Medicine: 4 fractional works · 0.7% of its workInfectious Diseases: 4 fractional works · 0.6% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 0.6% of its workPharmacology: 3 fractional works · 0.6% of its workOrthopedics and Sports Medicine: 3 fractional works · 0.6% of its workReproductive Medicine: 3 fractional works · 0.5% of its workNephrology: 2 fractional works · 0.4% of its workPsychiatry and Mental health: 2 fractional works · 0.3% of its workDermatology: 2 fractional works · 0.3% of its workHepatology: 2 fractional works · 0.3% of its workGastroenterology: 2 fractional works · 0.3% of its workRehabilitation: 1 fractional works · 0.2% of its workFamily Practice: 1 fractional works · 0.2% of its workSmaller subfields together: 7 fractional works · 1.3% of its workHealth Professions: 8 fractional works · 1.5% of its workGeneral Health Professions: 4 fractional works · 0.6% of its workHealth Information Management: 2 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.5% of its workNursing: 4 fractional works · 0.7% of its workNutrition and Dietetics: 3 fractional works · 0.5% of its workSmaller subfields together: 1 fractional works · 0.2% of its workDentistry: 1 fractional works · 0.1% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 140 fractional works · 24.3% of its workBiochemistry, Genetics and Molecular Biology: 95 fractional works · 16.7% of its workMolecular Biology: 64 fractional works · 11.1% of its workCancer Research: 14 fractional works · 2.4% of its workGenetics: 9 fractional works · 1.5% of its workCell Biology: 3 fractional works · 0.5% of its workBiotechnology: 2 fractional works · 0.3% of its workBiochemistry: 1 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.6% of its workImmunology and Microbiology: 20 fractional works · 3.4% of its workImmunology: 18 fractional works · 3.2% of its workMicrobiology: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPharmacology, Toxicology and Pharmaceutics: 11 fractional works · 1.9% of its workPharmacology: 5 fractional works · 0.9% of its workPharmaceutical Science: 4 fractional works · 0.8% of its workToxicology: 2 fractional works · 0.3% of its workNeuroscience: 8 fractional works · 1.5% of its workNeurology: 3 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 2 fractional works · 0.3% of its workCognitive Neuroscience: 1 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.4% of its workAgricultural and Biological Sciences: 5 fractional works · 0.9% of its workAnimal Science and Zoology: 1 fractional works · 0.2% of its workSmaller subfields together: 4 fractional works · 0.6% of its workPhysical Sciences: 62 fractional works · 10.8% of its workEngineering: 18 fractional works · 3.1% of its workBiomedical Engineering: 9 fractional works · 1.5% of its workMechanical Engineering: 3 fractional works · 0.5% of its workComputational Mechanics: 2 fractional works · 0.3% of its workSmaller subfields together: 4 fractional works · 0.7% of its workChemistry: 13 fractional works · 2.2% of its workOrganic Chemistry: 6 fractional works · 1.0% of its workSpectroscopy: 3 fractional works · 0.5% of its workAnalytical Chemistry: 2 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.3% of its workMathematics: 8 fractional works · 1.5% of its workStatistics and Probability: 8 fractional works · 1.5% of its workComputer Science: 8 fractional works · 1.4% of its workArtificial Intelligence: 3 fractional works · 0.5% of its workComputational Theory and Mathematics: 2 fractional works · 0.4% of its workComputer Vision and Pattern Recognition: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.2% of its workMaterials Science: 7 fractional works · 1.2% of its workMaterials Chemistry: 4 fractional works · 0.8% of its workBiomaterials: 2 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 4 fractional works · 0.8% of its workPhysics and Astronomy: 2 fractional works · 0.3% of its workChemical Engineering: 1 fractional works · 0.2% of its workCatalysis: 1 fractional works · 0.2% of its workEnergy: 1 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.0% of its workSocial Sciences: 48 fractional works · 8.5% of its workEconomics, Econometrics and Finance: 25 fractional works · 4.4% of its workEconomics and Econometrics: 25 fractional works · 4.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 8 fractional works · 1.3% of its workSociology and Political Science: 3 fractional works · 0.5% of its workSmaller subfields together: 5 fractional works · 0.9% of its workPsychology: 5 fractional works · 0.9% of its workSocial Psychology: 2 fractional works · 0.4% of its workClinical Psychology: 2 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.3% of its workDecision Sciences: 4 fractional works · 0.8% of its workManagement Science and Operations Research: 2 fractional works · 0.3% of its workStatistics, Probability and Uncertainty: 2 fractional works · 0.3% of its workInformation Systems and Management: 1 fractional works · 0.2% of its workArts and Humanities: 3 fractional works · 0.6% of its workBusiness, Management and Accounting: 3 fractional works · 0.5% of its workManagement of Technology and Innovation: 1 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.2% of its workALL ITS WORKDaiichi-Sankyo(Japan)573fractional works, 2022-now
Life Sciences24%Physical Sciences11%Health Sciences56%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Medicine31054.1%
    2. Health Professions81.5%
    3. Nursing40.7%
    4. Dentistry10.1%
    5. Veterinary00.1%
    1. Biochemistry, Genetics and Molecular Biology9516.7%
    2. Immunology and Microbiology203.4%
    3. Pharmacology, Toxicology and Pharmaceutics111.9%
    4. Neuroscience81.5%
    5. Agricultural and Biological Sciences50.9%
    1. Engineering183.1%
    2. Chemistry132.2%
    3. Mathematics81.5%
    4. Computer Science81.4%
    5. Materials Science71.2%
    6. Environmental Science40.8%
    7. Physics and Astronomy20.3%
    8. Chemical Engineering10.2%
    9. Energy10.2%
    10. Earth and Planetary Sciences00.0%
    1. Economics, Econometrics and Finance254.4%
    2. Social Sciences81.3%
    3. Psychology50.9%
    4. Decision Sciences40.8%
    5. Arts and Humanities30.6%
    6. Business, Management and Accounting30.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Daiichi-Sankyo (Japan) specialise in?

Where its research is concentrated relative to its size: Oncology takes 11.8× the share of its output that it takes of world research.

  1. OncologySubfield · 76.1 works12×
  2. Cardiology and Cardiovascular MedicineSubfield · 33.9 works5.6×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 5 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.12× its world share, 96 worksBiochemistry, Geneti…Immunology and Microbiology: 3.41× its world share, 20 worksImmunology and Micro…Neuroscience: 0.90× its world share, 8 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.52× its world share, 11 worksPharmacology, Toxico…Chemical Engineering: 0.58× its world share, 1 worksChemical EngineeringChemistry: 1.40× its world share, 13 worksChemistryComputer Science: 0.17× its world share, 8 worksComputer ScienceEarth and Planetary Sciences: 0.03× its world share, 0 worksEarth and Planetary …Energy: 0.17× its world share, 1 worksEnergyEngineering: 0.20× its world share, 18 worksEngineeringEnvironmental Science: 0.16× its world share, 4 worksEnvironmental ScienceMaterials Science: 0.34× its world share, 7 worksMaterials ScienceMathematics: 1.25× its world share, 8 worksMathematicsPhysics and Astronomy: 0.14× its world share, 2 worksPhysics and AstronomyDentistry: 0.20× its world share, 1 worksDentistryHealth Professions: 0.55× its world share, 8 worksHealth ProfessionsMedicine: 2.82× its world share, 310 worksMedicineNursing: 1.33× its world share, 4 worksNursingVeterinary: 0.60× its world share, 0 worksVeterinaryArts and Humanities: 0.20× its world share, 3 worksArts and HumanitiesBusiness, Management and Accounting: 0.14× its world share, 3 worksBusiness, Management…Decision Sciences: 0.81× its world share, 4 worksDecision SciencesEconomics, Econometrics and Finance: 2.05× its world share, 25 worksEconomics, Econometr…Psychology: 0.30× its world share, 5 worksPsychologySocial Sciences: 0.11× its world share, 8 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.5×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics5.52×11 works
  2. Immunology and Microbiology3.41×20 works
  3. Biochemistry, Genetics and Molecular Biology3.12×96 works
  4. Medicine2.82×310 works
  5. Economics, Econometrics and Finance2.05×25 works
  6. Chemistry1.40×13 works
  7. Nursing1.33×4 works
  8. Mathematics1.25×8 works
  9. Neuroscience0.90×8 works
  10. Decision Sciences0.81×4 works
  11. Veterinary0.60×0 works
  12. Chemical Engineering0.58×1 works
  13. Health Professions0.55×8 works
  14. Materials Science0.34×7 works
  15. Psychology0.30×5 works
  16. Engineering0.20×18 works
  17. Dentistry0.20×1 works
  18. Arts and Humanities0.20×3 works
  19. Agricultural and Biological Sciences0.18×5 works
  20. Computer Science0.17×8 works
  21. Energy0.17×1 works
  22. Environmental Science0.16×4 works
  23. Physics and Astronomy0.14×2 works
  24. Business, Management and Accounting0.14×3 works
  25. Social Sciences0.11×8 works
  26. Earth and Planetary Sciences0.03×0 works

Who are the top researchers at Daiichi-Sankyo (Japan)?

Ranked on the quality score, Yusuke Ogitani, Masanori Funabashi and Takashi Kagari lead among researchers whose main affiliation is Daiichi-Sankyo (Japan).

  1. 1 Yusuke Ogitani Japan · #127,171 worldwide 4.8k citations · 70 works
  2. 2 Masanori Funabashi Japan · #505,549 worldwide 3.2k citations · 93 works
  3. 3 Takashi Kagari Japan · #519,119 worldwide 1.5k citations · 130 works
  4. 4 Masahiro Sugihara Japan · #525,097 worldwide 4k citations · 67 works
  5. 5 Yasuyuki Okuda Japan · #594,682 worldwide 2.6k citations · 107 works
  6. 6 Hidehiko Furukawa Japan · #776,676 worldwide 5.5k citations · 41 works
  7. 7 Takahiro Jikoh Japan · #828,263 worldwide 1.9k citations · 53 works
  8. 8 Koichiro Inaki Japan · #829,393 worldwide 1.6k citations · 49 works
  9. 9 Kenji Hirotani Japan · #899,236 worldwide 1.5k citations · 147 works
  10. 10 Kaku Saito Japan · #916,249 worldwide 2.7k citations · 66 works
All ranked researchers at Daiichi-Sankyo (Japan)

What are the most cited papers from Daiichi-Sankyo (Japan)?

The most cited paper from Daiichi-Sankyo (Japan) is "Edoxaban versus Warfarin in Patients with Atrial Fibrillation" (Robert Patrick Giugliano et al., 2013), with 5,195 citations. Next come "Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis" (2,809) and "Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer" (2,702).

Most cited papers
#PaperReleasedCitations
1 Edoxaban versus Warfarin in Patients with Atrial Fibrillation Robert Patrick Giugliano et al. · New England Journal of Medicine Open access 19 Nov 2013 5,195
2 Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis Gabriele Bergers, Rolf A. Brekken, Gerald McMahon et al. · Nature Cell Biology Open access 20 Sep 2000 2,809
3 Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Shanu Modi et al. · New England Journal of Medicine Open access 5 Jun 2022 2,702
4 Cytochrome P-450 Polymorphisms and Response to Clopidogrel Jessica L. Mega, Sandra L. Close, Stephen D. Wiviott et al. · New England Journal of Medicine Open access 22 Dec 2008 2,503
5 Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain Monica R. P. Elmore, Allison R. Najafi, Maya A. Koike et al. · Neuron Open access Apr 2014 2,089
All 60 most cited papers, with filters and sorting

Which keywords describe research at Daiichi-Sankyo (Japan)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Chemotherapy, Breast Cancer, Clinical Trials, Monoclonal Antibody, Targeted Therapy, Trastuzumab, Receptor tyrosine kinases and Metastatic.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy64▲ 16×22 topics
  2. Breast Cancer43▲ 30×10 topics
  3. Clinical Trials39▲ 10×12 topics
  4. Monoclonal Antibody32▲ 103×2 topics
  5. Targeted Therapy30▲ 23×4 topics
  6. Trastuzumab29▲ 102×2 topics
  7. Receptor tyrosine kinases29▲ 130×2 topics
  8. Metastatic29▲ 76×2 topics
  9. EGFR29▲ 157×1 topic
  10. HER229▲ 157×1 topic
  11. Quality of Life27▲ 3.2×24 topics
  12. Inflammation24▲ 2.0×56 topics
  13. Prognostic Factors24▲ 9.4×11 topics
  14. Biomarkers22▲ 5.5×15 topics
  15. Immunotherapy21▲ 5.1×15 topics
  16. Clinical Practice Guidelines21▲ 6.6×11 topics
  17. Metastatic Breast Cancer20▲ 61×2 topics
  18. Monoclonal Antibodies19▲ 37×3 topics
  19. Guidelines19▲ 7.0×7 topics
  20. Anticoagulant Therapy18▲ 24×4 topics
  21. Glycosylation18▲ 28×3 topics
  22. Catheter Ablation17▲ 25×2 topics
  23. Therapeutic Antibodies17▲ 43×2 topics
  24. Genomic Profiling16▲ 27×2 topics
  25. Treatment Guidelines16▲ 13×3 topics
  26. Metastasis16▲ 8.2×11 topics
  27. Stroke Prevention16▲ 23×2 topics
  28. ALK Inhibitors16▲ 44×1 topic
  29. Atrial Fibrillation16▲ 27×1 topic
  30. EGFR Mutations16▲ 44×1 topic
  31. Risk Stratification16▲ 37×1 topic
  32. Radiotherapy15▲ 6.5×10 topics
  33. Survival Analysis14▲ 8.9×7 topics
  34. Genetic Variants13▲ 13×6 topics
  35. Antibody Engineering13▲ 40×1 topic
  36. Cost-effectiveness Analysis13▲ 28×1 topic
  37. Economic Evaluation13▲ 19×2 topics
  38. Fc Receptors13▲ 40×1 topic
  39. Health Utility Measures13▲ 28×1 topic
  40. Cell Cycle Control12▲ 60×2 topics

Which research topics does Daiichi-Sankyo (Japan) publish most on?

By volume in 2022-now: HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Atrial Fibrillation Management and Outcomes and Monoclonal and Polyclonal Antibodies Research.

HER2/EGFR in Cancer Rese…29HER2/EGFR in Cancer Research: 29 fractional worksLung Cancer Treatments and Mutations: 16 fractional worksAtrial Fibrillation Mana…16Atrial Fibrillation Management and Outcomes: 16 fractional worksMonoclonal and Polyclona…13Monoclonal and Polyclonal Antibodies Research: 13 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 13 fractional worksAdvanced Breast Cancer Therapies: 12 fractional worksLung Cancer Research Stu…9Lung Cancer Research Studies: 9 fractional worksCancer Treatment and Pharmacology: 9 fractional worksLipoproteins and Cardiovascular Health: 8 fractional worksBreast Cancer Treatment Studies: 7 fractional works
OncologyPulmonary and Respiratory MedicineCardiology and Cardiovascular MedicineRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 29 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 16 works
  3. 3 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 16 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 13 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 13 works
  6. 6 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 12 works
  7. 7 Lung Cancer Research Studies Oncology 9 works
  8. 8 Cancer Treatment and Pharmacology Oncology 9 works
  9. 9 Lipoproteins and Cardiovascular Health Surgery 8 works
  10. 10 Breast Cancer Treatment Studies Cancer Research 7 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.7%not open62.3%

World: 40% of research is openly available.

with international co-authors36.3%domestic only63.7%

World: 18% is written across borders.

How has Daiichi-Sankyo (Japan)'s research output changed?

Output in 2022-2025 was 1% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Daiichi-Sankyo (Japan) as a percentage of every work published that year, 0.0023% in 2024.

still counting0.0050%0.010%0.015%Daiichi-Sankyo (Japan)0.0023% in 202519801990200020102020

Fractional works of Daiichi-Sankyo (Japan) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting5%10%15%all institutions10.0% in 2025Daiichi-Sankyo (Japan)9.8% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 14.8% in 2019.

Other research institutions in Tokyo

All research institutions in Tokyo

Share Daiichi-Sankyo (Japan)'s ranking

Daiichi-Sankyo (Japan) on Science Explorer

A card with Daiichi-Sankyo (Japan)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Daiichi-Sankyo (Japan). Posts are plain text and can be reported.